My Cart

Anti-CD28 Antibody

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
ONL-1204ONL-1204Phase 2 ClinicalOnl TherapeuticsGlaucoma, Open-Angle; Retinal Detachment; Geographic Atrophy
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
KanglaiteApprovedZhejiang Kanglaite Pharmaceutical Co LtdKanglaiteMainland ChinaLiver Neoplasms; Carcinoma, Non-Small-Cell LungZhejiang Kanglaite Pharmaceutical Co Ltd1997-01-01Liver Neoplasms; Solid tumours; Neoplasms; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland